HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barkia, A. Articles by Fruchart, J. C. Search for Related Content PubMed PubMed Citation Articles by Barkia, A. Articles by Fruchart, J. C. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 29, 77-84, Copyright © 1988 by Lipid Research, Inc.

ARTICLES

Enzyme-linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptide

A Barkia, C Martin, P Puchois, JC Gesquiere, C Cachera, A Tartar and JC Fruchart
SERLIA, Institut Pasteur, Lille, France.

Apolipoprotein A-I (apoA-I), the major protein component of human high density lipoprotein, appears intracellularly as an intermediate precursor (proapoA-I) with a hexapeptide extension (Arg-His-Phe-Trp-Gln- Gln) at its amino terminus. To investigate the regulation of processes that regulate plasma apoA-I levels, a sensitive and simple assay for proapoA-I is required. We describe a specific enzyme-linked immunosorbent assay (ELISA) for quantification of proapoA-I using monospecific rabbit antibodies raised against the peptide: Arg-His-Phe- Trp-Gln-Gln-Asp-Glu-Pro. The monospecificity of antibodies to propeptide has been checked and no cross-reaction with mature apoA-I has been found although three first mature apoA-I amino acids (Asp-Glu- Pro) were included in the immunizing peptide. The assay is a non- competitive sandwich ELISA in which polystyrene microtiter plates were used with antibodies to propeptide adsorbed on the wells. After incubation with plasma samples, the bound proapoA-I was revealed by labeled rabbit polyclonal antibodies directed against mature apoA-I. The working range was 10 to 100 ng/ml, recovery of proapoA-I added to plasma was 94.6 to 106.5%, and the intra- and interassay coefficients of variation were 3.8% and 7.9%, respectively. A delipidation step using diisopropylether-n-butanol was necessary to expose antigen sites of proapoA-I in native lipoproteins. Mean level of proapoA-I in normal subjects was 87 +/- 15 micrograms/ml. It represented 7.1% of total apoA- I while in Tangier serum it represented 29%.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Ohara, Y. Kumon, T. Kobayashi, H. Takeuchi, and T. Sugiura Exocytosis of Neutrophil Formyl Peptide Receptor-Like 1 (fPRL1) Results in Downregulation of Cytoplasmic fPRL1 in Patients with Purulent Dermatitis Clin. Vaccine Immunol., June 1, 2007; 14(6): 678 - 684. [Abstract] [Full Text] [PDF]

				K.-i. Okuhira, M. Tsujita, Y. Yamauchi, S. Abe-Dohmae, K. Kato, T. Handa, and S. Yokoyama Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL J. Lipid Res., April 1, 2004; 45(4): 645 - 652. [Abstract] [Full Text] [PDF]

				J. Stocks, M. N. Nanjee, and N. E. Miller Analysis of high density lipoprotein apolipoproteins by capillary zone and capillary SDS gel electrophoresis J. Lipid Res., January 1, 1998; 39(1): 218 - 227. [Abstract] [Full Text]